Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    -0.11 (-8.40%)
Bid:
1.10
Ask:
1.30
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Strategic Update

21 Jul 2022 13:33

RNS Number : 3395T
Tern PLC
21 July 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018). UPON THE PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN.

 

21 July 2022

 

Tern Plc

("Tern" or the "Company")

 

Strategic Update

 

Tern Plc (AIM:TERN), the company focused on value creation from Internet of Things ("IoT") technology businesses, is providing an update on the Company's strategy following the termination of its proposed acquisition of Pires Investments plc ("Pires"), announced earlier today.

 

The board of Tern (the "Board") believes that the last two years have been pivotal for all of Tern's network of companies* and believes that they are all now well positioned for the future.

 

Tern has, with its hands-on approach, supported the growth of its companies from their early start-up days to now, alongside validation from independent third-party investors, who invested after conducting thorough due diligence. The Board believes that these third-party investments demonstrate confidence in the companies' management teams, business models, market focus and future prospects. These actions in the past eighteen months have resulted in uplifts in their carried values for our shareholders, delivered important investors to help them achieve market relevance and have enabled them to gain important commercial traction and grow their monthly recurring revenues ("MRR").

 

Whilst the Board believes that all of the companies in Tern's network are capable of further value enhancing growth under Tern's stewardship, the Board recognises the views expressed by a segment of the Company's shareholders who wish to see further demonstrations of the ability of the Tern business model to crystalise value for shareholders, specifically through the exit of an existing holding before further companies are added to the network of companies.

 

July 2021 saw the first IPO of one of Tern's companies, Wyld Networks AB, on the NASDAQ First North Growth Market in Stockholm, transforming Tern's holding from one of a venture investor to an institutional investor. The public quotation of Wyld Networks now provides Tern with access to capital and ultimately a route to exit its participation at the appropriate time, to further maximise value for Tern shareholders. However, the Board believes that Wyld Networks has significant future potential and that a sizable reduction in Tern's holding would not be in shareholders' or the Company's best interests at the present time.

 

The Board is therefore reviewing all of Tern's other holdings with a target to achieve a realisation of one or more of the Company's participations as soon as economically prudent and feasible. Whilst there can be no guarantee that buyers will be available at an appropriate price for any of Tern's holdings, particularly given the current financial market conditions, the Board is focused on achieving this target as soon as it is appropriate and realistic in the Board's view.

 

The Board also recognises both the desire to protect Tern's current positions in its network of companies and the limited appetite of some shareholders to see further companies added to Tern's network, at least until one or more exits have been achieved. Therefore, the Board's current intention is not to add any new companies to the Tern network of companies, other than to meet any commitment the Company may have in relation to the Sure Valley Ventures UK Software Technology Fund, until it has received a capital return from an exit of one of its current investments.

 

However, it is important to note that Tern's companies are all in an MRR growth phase and may require further funding if they are to realise their full potential and deliver appropriate returns to all their shareholders, including Tern and its shareholders. Funding therefore may be required ahead of the receipt of any exit proceeds and in that event the Board will seek to explore all the funding sources and options available to the Company, together with the appropriateness of participating in any capital raise being undertaken by one of Tern's companies, in order to protect the gains and value creation already achieved for Tern's shareholders and to ensure the Company is able to negotiate from a position of strength.

 

The focus, therefore, at least in the short to medium term, will be on Tern's existing companies and the Company's existing significant pipeline of exciting and disruptive potential investment opportunities will be put on hold at the present time. In light of this, the Board will also be assessing its structure to ensure that it is configured to best meet the Company's and its network of companies' immediate needs.

 

Further announcements will be made in due course, as appropriate.

 

\* Tern's "network of companies" or "Tern's companies" comprise: Device Authority Limited, Wyld Networks AB, InVMA Limited (trading as Konektio), FVRVS Limited (Trading as FundamentalVR) and Talking Medicines Limited, which are companies that Tern has interests in, together with Tern's holding in the Sure Valley Ventures UK Software Technology Fund.

Commenting Al Sisto, CEO of Tern, said:

 

"As was outlined in the various transaction announcements and the circular to Tern shareholders, we believed that the acquisition of Pires could have delivered substantial benefits to Tern shareholders. Therefore, whilst it is disappointing that the acquisition of Pires has not proceeded, we are determined to continue to execute our strategy and maximise value for Tern shareholders, both in the short and long term. 

 

"Tern's companies have all made important progress in the last eighteen months, despite the pandemic, and we recognise the desire of many shareholders to see this demonstrated through an exit. We will therefore be carefully evaluating how best this may be achieved, whilst continuing to improve those in our network of companies that we believe have the potential to deliver significantly higher returns to their shareholders, including Tern and its shareholders.

 

"The Board remains fully focussed on continuing to maximise value for Tern shareholders and I look forward to making further announcements in due course."

 

Enquiries

 

Tern Plc

Al Sisto (CEO)

Sarah Payne (CFO)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

David Worlidge / Alex Brearley (Corporate Finance)

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

 

Tel: 0203 328 5656

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

Tel: 0203 934 6630

tern@investor-focus.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFVFDIILFIF
Date   Source Headline
13th Apr 20219:05 amRNSSecond Price Monitoring Extn
13th Apr 20219:00 amRNSPrice Monitoring Extension
6th Apr 20214:40 pmRNSSecond Price Monitoring Extn
6th Apr 20214:35 pmRNSPrice Monitoring Extension
6th Apr 20212:06 pmRNSSecond Price Monitoring Extn
6th Apr 20212:00 pmRNSPrice Monitoring Extension
31st Mar 20217:01 amRNSDA convertible loan note maturity date extension
31st Mar 20217:00 amRNSFinal results for the year ended 31 December 2020
29th Mar 20213:40 pmRNSAIM Director Disclosure Update
29th Mar 20212:00 pmRNSPrice Monitoring Extension
25th Mar 202111:00 amRNSPrice Monitoring Extension
24th Mar 20212:06 pmRNSSecond Price Monitoring Extn
24th Mar 20212:00 pmRNSPrice Monitoring Extension
18th Mar 20214:41 pmRNSSecond Price Monitoring Extn
18th Mar 20214:35 pmRNSPrice Monitoring Extension
18th Mar 20212:06 pmRNSSecond Price Monitoring Extn
18th Mar 20212:00 pmRNSPrice Monitoring Extension
18th Mar 202111:05 amRNSSecond Price Monitoring Extn
18th Mar 202111:00 amRNSPrice Monitoring Extension
17th Mar 20212:06 pmRNSSecond Price Monitoring Extn
17th Mar 20212:01 pmRNSPrice Monitoring Extension
2nd Mar 20217:00 amRNSPortfolio News
11th Feb 20212:05 pmRNSSecond Price Monitoring Extn
11th Feb 20212:00 pmRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSFundamentalVR and Device Authority Update
4th Feb 20217:00 amRNSPortfolio Update
28th Jan 20217:00 amRNSWyld Networks Fundraise and Update
15th Jan 202111:05 amRNSSecond Price Monitoring Extn
15th Jan 202111:00 amRNSPrice Monitoring Extension
13th Jan 20212:06 pmRNSSecond Price Monitoring Extn
13th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 202111:05 amRNSSecond Price Monitoring Extn
13th Jan 202111:00 amRNSPrice Monitoring Extension
12th Jan 20217:00 amRNSPortfolio Update
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:35 pmRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSFurther FundamentalVR contract win
1st Dec 20205:30 pmRNSTotal Voting Rights
1st Dec 20207:00 amRNSFundamentalVR contract win
24th Nov 20207:00 amRNSFundamentalVR secures three-year follow on order
13th Nov 20204:41 pmRNSSecond Price Monitoring Extn
13th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Nov 20207:00 amRNSResult of Fundraise
12th Nov 20204:36 pmRNSRetail Offer
12th Nov 20204:35 pmRNSEquity Fundraise of up to £2.2 million
10th Nov 20207:00 amRNSPortfolio Update
4th Nov 20207:00 amRNSInvestment in Talking Medicines Limited
2nd Nov 20204:41 pmRNSSecond Price Monitoring Extn
2nd Nov 20204:35 pmRNSPrice Monitoring Extension
30th Oct 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.